Royal Bank of Canada’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
130,995
-394
-0.3% -$8.15K ﹤0.01% 2970
2026
Q1
$2.26M Buy
131,389
+13,746
+12% +$283K ﹤0.01% 3001
2025
Q4
$2.75M Buy
117,643
+65,887
+127% +$1.7M ﹤0.01% 2893
2025
Q3
$1.64M Buy
51,756
+19,129
+59% +$577K ﹤0.01% 3567
2025
Q2
$927K Buy
32,627
+996
+3% +$29.9K ﹤0.01% 3959
2025
Q1
$976K Buy
31,631
+21
+0.1% +$713 ﹤0.01% 3504
2024
Q4
$1.05M Buy
31,610
+5,176
+20% +$176K ﹤0.01% 3504
2024
Q3
$800K Buy
26,434
+10,964
+71% +$342K ﹤0.01% 3721
2024
Q2
$437K Buy
15,470
+5,649
+58% +$177K ﹤0.01% 4126
2024
Q1
$363K Buy
9,821
+8,314
+552% +$311K ﹤0.01% 4188
2023
Q4
$62K Buy
1,507
+976
+184% +$31.3K ﹤0.01% 5892
2023
Q3
$17K Buy
531
+46
+9% +$1.78K ﹤0.01% 6241
2023
Q2
$20K Buy
+485
New +$19.8K ﹤0.01% 6221
2022
Q4
Sell
-14
Closed 7668
2022
Q3
$0 Buy
14
+13
+1,300% +$364 ﹤0.01% 7817
2022
Q2
$0 Hold
1
﹤0.01% 7686
2022
Q1
$0 Buy
+1
New +$25 ﹤0.01% 7986
2021
Q4
Sell
-2,000
Closed -$69K 7870
2021
Q3
$69K Hold
2,000
﹤0.01% 5966
2021
Q2
$74K Buy
+2,000
New +$58.5K ﹤0.01% 5780

Other funds holding SMTI

Royal Bank of Canada's SMTI Position: Q2 2026 in Review

Royal Bank of Canada reduced its Sanara MedTech (SMTI) stake by 0.3% in Q2 2026, selling an estimated $8.15K and leaving 130,995 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

Royal Bank of Canada first reported a position in SMTI in Q2 2021 and has held it in 18 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Royal Bank of Canada held 130,995 shares of Sanara MedTech worth $3.09M as of Q2 2026.
  • Royal Bank of Canada sold 394 Sanara MedTech shares in Q2 2026, an estimated $8.15K.
  • Sanara MedTech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2970 holding.
  • Royal Bank of Canada first reported a position in Sanara MedTech in Q2 2021 and has held it in 18 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.